首页> 外文OA文献 >Combined use of furosemide with selective and nonselective B-adrenergic antagonists for treatment of edematous syndrome associated with chronic circulatory failure in rats
【2h】

Combined use of furosemide with selective and nonselective B-adrenergic antagonists for treatment of edematous syndrome associated with chronic circulatory failure in rats

机译:速尿联合选择性和非选择性B-肾上腺素能拮抗剂联合治疗大鼠慢性循环衰竭相关的水肿综合征

摘要

Nowadays, a viewpoint about the increased activity of renin-angiotensin and sympathoadrenal systems in patients with edematous syndrome due to circulatory failure is generally accepted. Activation of these humoral systems in case of congestive heart failure and in cases of number of other cardiovascular diseases causes homeostatic reaction of kidneys which accompanied by the increase of sodium reabsorption in nephron and water retention in organism. This effect partly is result of stimulation of β-adrenergic receptors of renal tubules and of juxtaglomerular cells producing renin. Therefore, it is possible that β-adrenergic antagonists can cause in such conditions diuretic and natriuretic reactions which may be used for correction of water and electrolyte disturbances in diseases accompanied by increased activity of sympathoadrenal system.When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123456789/35799
机译:如今,关于因循环衰竭而引起的水肿综合征患者肾素-血管紧张素和交感肾上腺系统活性增加的观点已被普遍接受。在充血性心力衰竭和许多其他心血管疾病的情况下,这些体液系统的激活引起肾脏的体内稳态反应,其伴随着肾单位中钠的重吸收增加和生物体中的水分保留。该作用部分是刺激肾小管和产生肾素的肾小球细胞的β-肾上腺素受体的结果。因此,β-肾上腺素拮抗剂可能会在这种情况下引起利尿和利尿钠反应,这些反应可用于纠正疾病和伴有交感肾上腺系统活性增强的疾病中的水和电解质紊乱。链接http://essuir.sumdu.edu.ua/handle/123456789/35799

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号